Anaptysbio (ANAB) Long-Term Investments (2017 - 2025)

Anaptysbio's Long-Term Investments history runs 9 years deep, the most recent figure standing at $7.7 million for Q3 2025.

• Quarterly Long-Term Investments fell 72.42% year-over-year to $7.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $7.7 million (down 72.42% YoY) and the FY2024 annual result came in at $35.5 million, up 31.24% from the prior year.
• Long-Term Investments was $7.7 million for Q3 2025 at Anaptysbio, down from $28.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $147.5 million in Q3 2022 and bottomed at $5.5 million in Q2 2021.
• A 5-year average of $54.1 million and a median of $40.2 million in 2023 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2021 — Long-Term Investments sank 85.95% — and 2022, when it surged 2270.26%.
• Anaptysbio's Long-Term Investments stood at $67.1 million in 2021, then soared by 113.03% to $142.9 million in 2022, then tumbled by 81.09% to $27.0 million in 2023, then soared by 31.24% to $35.5 million in 2024, then slumped by 78.3% to $7.7 million in 2025.
• Business Quant data shows ANAB's Long-Term Investments at $7.7 million in Q3 2025, $28.0 million in Q2 2025, and $43.0 million in Q1 2025.